Company: PACB
Filing Date: 2025-03-17
Form Type: 10-K
Source: 0001299130-25-000061
Chunk: 320

Company: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Filing Date: 2025-03-17
Form: 10-K
Item: Item 1
Chunk 320
---
paid expenses and other current assets 18,781 17,040 Short-term restricted cash690 300 Total current assets 495,681 742,047 Property and equipment, net 30,505 36,432 Operating lease right-of-use assets, net 16,091 32,593 Long-term restricted cash1,532 2,422 Intangible assets, net389,572 456,984 Goodwill317,761 462,261 Other long-term assets 9,305 13,274 Total assets $1,260,447 $1,746,013 Liabilities and Stockholders’ Equity Current liabilitiesAccounts payable $16,590 $15,062 Accrued expenses 22,595 45,708 Deferred revenue, current 13,864 16,342 Operating lease liabilities, current10,026 9,591 Other liabilities, current 3,224 8,326 Total current liabilities 66,299 95,029 Deferred revenue, non-current 5,900 5,530 Contingent consideration liability, non-current18,700 19,550 Operating lease liabilities, non-current 14,914 31,606 Convertible senior notes, net, non-current647,494 892,243 Other liabilities, non-current 546 751 Total liabilities 753,853 1,044,709 Commitments and contingencies Stockholders’ equityPreferred stock, $0.001 par value:Authorized 50,000 shares; No shares issued or outstanding — — Common stock, $0.001 par value:Authorized 1,000,000 shares; issued and outstanding 294,418 and 267,744 shares at December 31, 2024 and December 31, 2023, respectively 294 268 Additional paid-in capital 2,654,804 2,539,892 Accumulated other comprehensive income422 219 Accumulated deficit (2,148,926)(1,839,075)Total stockholders’ equity 506,594 701,304 Total liabilities and stockholders’ equity $1,260,447 $1,746,013 

See accompanying notes to the consolidated financial statements. 

Fiscal 2024 Form 10-K85

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.CONSOLIDATED STATEMENTS OF OPERATIONS